Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan
ABSTRACT The latest guidelines include azithromycin as a preferred regimen for treating Mycobacterium avium complex (MAC) pulmonary disease. However, serially collected susceptibility data on clinical MAC isolates are limited, and no breakpoints have been determined. We investigated the minimum inhi...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2024-06-01
|
| Edice: | Microbiology Spectrum |
| Témata: | |
| On-line přístup: | https://journals.asm.org/doi/10.1128/spectrum.00218-24 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
